8-K: Hims & Hers Health Prices $1 Billion Convertible Notes Offering

Hims & Hers Health issues $1 billion in convertible senior notes due 2030, with a zero percent interest rate, to qualified institutional buyers.

Summary

• Hims & Hers Health, Inc. issued $1 billion aggregate principal amount of 0.00% Convertible Senior Notes due 2030 on May 13, 2025.
• The notes were offered to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933.
• The initial conversion rate is 14.1493 shares of the company's Class A common stock per $1,000 principal amount of notes, representing an initial conversion price of approximately $70.67 per share.
• The conversion rate is subject to adjustments for certain events.
• The company granted initial purchasers an option to purchase an additional $130.0 million aggregate principal amount of notes, which was exercised in full on May 9, 2025.
• The company may redeem the notes for cash on or after May 19, 2028, if certain liquidity and stock price conditions are met.
• Noteholders may require the company to repurchase their notes upon the occurrence of a fundamental change at a price equal to the principal amount plus accrued and unpaid interest.
• The company entered into capped call transactions with option counterparties to reduce potential dilution upon conversion of the notes.
• The cap price of the capped call transactions is initially $89.95 per share, representing a 75.0% premium over the Class A common stock price on May 8, 2025.
• The cost of the capped call transactions was approximately $47.8 million.

Sentiment

Score: 7

Explanation: The document is factual and descriptive, outlining the terms of a financial transaction. The sentiment is neutral to slightly positive, as the company is securing financing for future growth.

Positives

• The capped call transactions are expected to reduce potential dilution to the company's Class A common stock upon conversion of the notes.
• The zero percent interest rate on the convertible notes reduces the company's cash interest expense.

Negatives

• The notes are effectively subordinated to the company's existing and future secured indebtedness.
• The notes are structurally subordinated to all existing and future indebtedness and other liabilities of the company's subsidiaries.

Risks

• Noteholders may require the company to repurchase their notes upon the occurrence of a fundamental change, which could require the company to use a significant amount of cash.
• The company's ability to redeem the notes is subject to certain liquidity and stock price conditions, which may not be met.
• The capped call transactions may not fully offset the dilutive effect of conversion of the notes.

Future Outlook

The company may redeem the notes on or after May 19, 2028, if certain liquidity and stock price conditions are met. Noteholders may convert their Notes at any time from, and including, November 15, 2029 until the Close of Business on the second (2nd) Scheduled Trading Day immediately before the Maturity Date.

Industry Context

Convertible notes are a common financing tool for growth companies, allowing them to raise capital without immediate equity dilution. The capped call transactions are a standard way to manage potential dilution from the convertible notes.

Comparison to Industry Standards

• The terms of the convertible notes, such as the zero percent interest rate and the conversion price, are within the range of what is typically seen in the market for similar companies.
• The capped call transactions are also a common hedging strategy used by companies issuing convertible notes.
• Comparable companies that have issued convertible notes with capped call transactions include Tesla, Square, and Beyond Meat.

Stakeholder Impact

• Shareholders may experience dilution upon conversion of the notes, although this is partially mitigated by the capped call transactions.
• The company's creditors will be structurally senior to the noteholders.
• The company's employees and customers are not directly impacted by this transaction.

Next Steps

• The company will use the proceeds from the offering for general corporate purposes.
• The company will monitor the stock price and liquidity conditions to determine whether to redeem the notes on or after May 19, 2028.
• The company will manage the conversion of the notes and the related dilution through the capped call transactions.

Key Dates

Keywords

convertible notes, capped call, Hims & Hers Health, Rule 144A, dilution, redemption, repurchase, fundamental change, senior notes, conversion